THE RELATIONSHIP BETWEEN METABOLIC SYNDROME AND CARDIAC MORPHOLOGY - A STUDY ON PATHOPHYSIOLOGICAL MECHANISMS AND CORRECTION APPROACHES
Ключевые слова:
Metabolic syndrome, heart morphology, left ventricular hypertrophy, myocardial fibrosis, insulin resistance, cardiovascular risk, pathophysiological mechanisms, oxidative stress, chronic inflammation, treatment approachesАннотация
Metabolic syndrome (MetS) is a cluster of interconnected risk factors, including abdominal obesity, hypertension, dyslipidemia, and insulin resistance, which significantly increase the likelihood of developing cardiovascular diseases. Recent studies highlight the critical role of heart morphology changes in individuals with MetS, contributing to cardiovascular dysfunction. This study explores the relationship between MetS and cardiac morphology, focusing on structural alterations such as left ventricular hypertrophy, myocardial fibrosis, and changes in chamber dimensions. The underlying pathophysiological mechanisms, including insulin resistance, oxidative stress, and chronic inflammation, are examined in relation to these changes. The article also discusses potential correction approaches, emphasizing the importance of early detection and targeted treatment strategies to mitigate the long-term cardiovascular risks associated with MetS.
Библиографические ссылки
Иргашев, И. Э. (2024). ПРИНЦИПЫ ПРИОРИТЕТА И ЕГО ЗНАЧЕНИЕ ОКАЗАНИЯ ПЕРВОЙ ПОМОЩИ У БОЛЬНЫХ ОСТРЫМ КОРОНАРНЫМ СИНДРОМОМ. TADQIQOTLAR. UZ, 34(2), 177-184.
Tokhirovna, E. G. (2024). MECHANISM OF ACTION OF METFORMIN (BIGUANIDE) IN TYPE 2 DIABETES. JOURNAL OF HEALTHCARE AND LIFE-SCIENCE RESEARCH, 3(5), 210-216.
Tokhirovna, E. G. (2024). THE ROLE OF METFORMIN (GLIFORMIN) IN THE TREATMENT OF PATIENTS WITH TYPE 2 DIABETES MELLITUS. EUROPEAN JOURNAL OF MODERN MEDICINE AND PRACTICE, 4(4), 171-177.
Эргашева, Г. Т. (2024). СНИЖЕНИЕ РИСКА ОСЛОЖНЕНИЙ У БОЛЬНЫХ САХАРНЫМ ДИАБЕТОМ 2 ТИПА И СЕРДЕЧНО-СОСУДИСТЫМИ ЗАБОЛЕВАНИЯМИ. ОБРАЗОВАНИЕ НАУКА И ИННОВАЦИОННЫЕ ИДЕИ В МИРЕ, 38(7), 210-218.
Нарзуллаева, У., Самиева, Г., & Пардаева, З. (2020). ПАТОФИЗИОЛОГИЯ РЕПЕРФУЗИОННОГО ПОВРЕЖДЕНИЯ МИОКАРДА. Журнал вестник врача, 1(2), 155-158.
Эргашева, Г. Т. (2024). СОСУЩЕСТВОВАНИЕ ДИАБЕТА 2 ТИПА И СЕРДЕЧНО-СОСУДИСТЫХ ЗАБОЛЕВАНИЙ У ПАЦИЕНТОВ. ОБРАЗОВАНИЕ НАУКА И ИННОВАЦИОННЫЕ ИДЕИ В МИРЕ, 38(7), 219-226.
Zikrillaev, F. A. (2024). Cardiorehabilitations from Physiotherapeutic Treatments in Cardiovascular Diseases. American Journal of Bioscience and Clinical Integrity, 1(10), 96-102.
Зикриллаев, Ф. А. (2024). ОПРЕДЕЛЕНИЕ РАННИХ ФАКТОРОВ РИСКА ХРОНИЧЕСКОЙ БОЛЕЗНИ ПОЧЕК В ПУБЕРТНОМ ВОЗРАСТЕ. Modern education and development, 16(7), 166-180.
Зикриллаев, Ф. А. (2024). РОЛЬ ПРЕПАРАТОВ ЛЕРКАНИДИПИНА И АМЛОДИПИНА В ЛЕЧЕНИИ АРТЕРИАЛЬНОЙ ГИПЕРТЕНЗИИ ПРИ ХРОНИЧЕСКОЙ БОЛЕЗНИ ПОЧЕК. Modern education and development, 16(7), 213-229.
Abdurashitovich, Z. F. (2024). DETERMINATION OF THE ETIOPATHOGENESIS AND RISK FACTORS OF OBESITY AMONG ADOLESCENTS. Modern education and development, 16(7), 181-194.
Abdurashitovich, Z. F. (2024). EARLY RISK FACTORS FOR ARTERIAL HYPERTENSION AND FEATURES OF ITS ASSOCIATION WITH OTHER DISEASES. Modern education and development, 16(7), 195-212.
Ergasheva, G. (2023). METHODS TO PREVENT SIDE EFFECTS OF DIABETES MELLITUS IN SICK PATIENTS WITH TYPE 2 DIABETES. International Bulletin of Medical Sciences and Clinical Research, 3(10), 104-108.
Ergasheva, G. T. (2022). QANDLI DIABET BILAN KASALLANGANLARDA REABILITATSIYA MEZONLARINI TAKOMILASHTIRISH. TA'LIM VA RIVOJLANISH TAHLILI ONLAYN ILMIY JURNALI, 2(12), 335-337.
ГТ, Э., & Саидова, Л. Б. (2022). СОВЕРШЕНСТВОВАНИЕ РЕАБИЛИТАЦИОННО-ВОССТАНОВИТЕЛЬНЫХ КРИТЕРИЕВ БОЛЬНЫХ С СД-2 ТИПА. TA'LIM VA RIVOJLANISH TAHLILI ONLAYN ILMIY JURNALI, 2(12), 206-209.
Toxirovna, E. G. (2023). O’RTA VA KEKSA YOSHLI BEMORLARDA 2-TUR QANDLI DIABET KECHISHINING KLINIKO-MORFOLOGIK XUSUSIYATLARI. ОБРАЗОВАНИЕ НАУКА И ИННОВАЦИОННЫЕ ИДЕИ В МИРЕ, 33(1), 164-166.
Abdurashitovich Z. F. ODAM ANATOMIYASI FANIDAN KALLA SUYAKLARI TUZILISHI VA SHAKLLANISHI HAQIDA //Modern education and development. – 2024. – Т. 16. – №. 7. – С. 149-165.
Zikrillaev, F. A. (2024). Metabolic Syndrome Calling Models. American Journal of Bioscience and Clinical Integrity, 1(11), 66-71.
Abdurashitovich, Z. F. (2024). MUSHAKLAR TO’GRISIDA MA’LUMOT. MUSHAKLARNING TARAQQIYOTI. MUSHAKLARNING YORDAMCHI APPARATI. TADQIQOTLAR. UZ, 40(3), 94-100.
Abdurashitovich, Z. F. (2024). APPLICATION OF MYOCARDIAL CYTOPROTECTORS IN ISCHEMIC HEART DISEASES. ОБРАЗОВАНИЕ НАУКА И ИННОВАЦИОННЫЕ ИДЕИ В МИРЕ, 39(5), 152-159.
Abdurashitovich, Z. F. (2024). SIGNIFICANCE OF BIOMARKERS IN METABOLIC SYNDROME. EUROPEAN JOURNAL OF MODERN MEDICINE AND PRACTICE, 4(9), 409-413.
Zikrillaev, F. A. (2024). Cardiorehabilitations from Physiotherapeutic Treatments in Cardiovascular Diseases. American Journal of Bioscience and Clinical Integrity, 1(10), 96-102.
